Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 14/20 | 0.71 |
| ▸ | MME | P08473 | 14/20 | 0.71 |
| ▸ | CPA1 | P15085 | 11/20 | 0.71 |
| ▸ | ACE2 | Q9BYF1 | 11/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8724267 | 1.00 | ACE (0.71) | ACEMMECPA1ACE2 | |
| SCHEMBL30051600 | 0.97 | ACE (0.68) | ACEMMECPA1ACE2 | |
| SCHEMBL30051286 | 0.95 | ACE (0.65) | ACEMMECPA1ACE2 | |
| SCHEMBL30051481 | 0.94 | ACE (0.64) | ACEMMECPA1ACE2 | |
| SCHEMBL30592752 | 0.94 | ACE (0.64) | ACEMMECPA1ACE2 | |
| SCHEMBL4985114 | 0.93 | ACE (0.62) | ACEMMECPA1ACE2 | |
| SCHEMBL4985096 | 0.93 | ACE (0.62) | ACEMMECPA1ACE2 | |
| SCHEMBL30728893 | 0.93 | MME (0.66) | ACEMMECPA1ACE2 | |
| SCHEMBL30052596 | 0.93 | ACE (0.62) | ACEMMECPA1ACE2 | |
| SCHEMBL30713700 | 0.92 | ACE (0.61) | ACEMMECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | HAIKOU QIAOSHUI UNITED TECHNOLOGY CO. LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4619412-A2 | PEPTIDES | Carocell Bio Limited (GB) | 2025-09-24 | — | — | EP | claimed |
| WO-2024235082-A1 | USE OF SARDINE PEPTIDE COMPOSITION IN DRUG FOR TREATING ALLERGIC RHINITIS | 海口桥水联合科技有限责任公司 | 2024-11-21 | — | — | WO | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| CN-115073550-B | Dipeptide difunctional small molecule compound for activating enzyme catalytic reaction and application thereof | 中国科学院青岛生物能源与过程研究所 | 2024-10-08 | — | — | CN | claimed |
| CN-118307633-A | Antarctic krill ACE (angiotensin converting enzyme) inhibitory peptide LGGIF, YLGGAL, LGGLNQ and application thereof | 中国水产科学研究院黄海水产研究所 | 2024-07-09 | — | — | CN | claimed |
| CN-117567562-B | Antarctic krill ACE (angiotensin converting enzyme) inhibitory peptide as well as preparation method and application thereof | 中国水产科学研究院黄海水产研究所 | 2024-06-04 | — | — | CN | claimed |
| WO-2024105410-A2 | PEPTIDES | Carocell Bio Limited (GB) | 2024-05-23 | — | — | WO | claimed |
| CN-117567562-A | Antarctic krill ACE (angiotensin converting enzyme) inhibitory peptide as well as preparation method and application thereof | 中国水产科学研究院黄海水产研究所 | 2024-02-20 | — | — | CN | claimed |
| CN-117486969-A | Preparation method and application of bamboo shoot flavor peptide | 天津春发生物科技集团有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-115651068-A | Cyclo-C-casein-isoleucin-phenylpropanoid with hepatoma carcinoma cytotoxicity and alpha-glucosidase inhibition activity and preparation method thereof | 安徽农业大学 | 2023-01-31 | — | — | CN | claimed |
| CN-115636871-A | Cyclochrolo-threo-casein-isoleucin-phenylpropyl peptide with hepatoma carcinoma cytotoxicity and alpha-glucosidase inhibition activity and preparation method thereof | 安徽农业大学 | 2023-01-24 | — | — | CN | claimed |
| US-20180275144-A1 | DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE | PHARNEXT (FR) | 2018-09-27 | — | — | US | claimed |
| WO-2016124574-A1 | DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE | PHARNEXT (FR) | 2016-08-11 | — | — | WO | claimed |
| WO-2013188333-A1 | BIOMARKERS RELATED TO NEPHROTOXICITY AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-12-19 | — | — | WO | claimed |
| US-20260132222-A1 | PROTEINS SPECIFIC FOR BAFF AND B7RP1 AND USES THEREOF | AMGEN INC. (US) | 2026-05-14 | — | — | US | disclosed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| EP-0211580-A2 | Renin inhibiting polypeptides and intermediates therefor | PFIZER INC. (US) | 1987-02-25 | — | — | EP | disclosed |
| US-4599198-A | Intermediates in polypeptide synthesis | PFIZER INC. (US) | 1986-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132222-A1 | PROTEINS SPECIFIC FOR BAFF AND B7RP1 AND USES THEREOF | SSB, IGSF11, CD22 | ACE 4384/4885MME 3398/4885CPA1 759/4885 |
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | ACE 1190/4885MME 824/4885CPA1 245/4885 |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | VIP, ANPEP, RNPEP | ACE 132/4885MME 112/4885CPA1 81/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.